Show simple item record

dc.contributor.authorRoug, Anne S.
dc.contributor.authorLarsen, Hanne O.
dc.contributor.authorNederby, Line
dc.contributor.authorJust, Tom
dc.contributor.authorBrown, Gordon
dc.contributor.authorNyvold, Charlotte G.
dc.contributor.authorOmmen, Hans B.
dc.contributor.authorHokland, Peter
dc.date.accessioned2018-10-17T23:06:33Z
dc.date.available2018-10-17T23:06:33Z
dc.date.issued2014-01-01
dc.identifier.citationRoug , A S , Larsen , H O , Nederby , L , Just , T , Brown , G , Nyvold , C G , Ommen , H B & Hokland , P 2014 , ' HMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemia ' , British Journal of Haematology , vol. 164 , no. 2 , pp. 212-222 . https://doi.org/10.1111/bjh.12614en
dc.identifier.issn0007-1048
dc.identifier.otherPURE: 139691843
dc.identifier.otherPURE UUID: f70e9dae-8db3-4b36-b9a0-44570771c78c
dc.identifier.otherScopus: 84891624172
dc.identifier.otherPubMed: 24152218
dc.identifier.urihttp://hdl.handle.net/2164/11285
dc.descriptionThe work was supported by grants to PH from The Danish Cancer Society, The Danish MRC, The John and Birthe Meyer Foundation, and the Karen Elise Jensen Foundation. GB has received funding from The Wellcome Trust. We thank our patients for contributing samples, and for continuous input during these efforts.en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofBritish Journal of Haematologyen
dc.rights© 2013 The Authors. British Journal of Haematology published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/3.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAcute myeloid leukaemiaen
dc.subjectFlow cytometryen
dc.subjectLeukaemia-associated immunophenotypeen
dc.subjectMinimal residual diseaseen
dc.subjectQuantitative polymerase chain reactionen
dc.subjectR Medicine (General)en
dc.subjectHematologyen
dc.subjectWellcome Trusten
dc.subject.lccR1en
dc.titleHMICL and CD123 in combination with a CD45/CD34/CD117 backbone : a universal marker combination for the detection of minimal residual disease in acute myeloid leukaemiaen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1111/bjh.12614
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=84891624172&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record